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Abstract
Despite robust postmortem evidence and potential clinical importance of gray
matter (GM) pathology in multiple sclerosis (MS), assessing GM damage by con-
ventional magnetic resonance imaging (MRI) remains challenging. This prospective
cross-sectional study aimed at characterizing the topography of GM microstruc-
tural and volumetric alteration in MS using, in addition to brain atrophy measures,
three quantitative MRI (qMRI) parameters—magnetization transfer (MT) saturation,
longitudinal (R1), and effective transverse (R2*) relaxation rates, derived from data
acquired during a single scanning session. Our study involved 35 MS patients
(14 relapsing–remitting MS; 21 primary or secondary progressive MS) and
36 age-matched healthy controls (HC). The qMRI maps were computed and seg-
mented in different tissue classes. Voxel-based quantification (VBQ) and voxel-
based morphometry (VBM) statistical analyses were carried out using multiple lin-
ear regression models. In MS patients compared with HC, three configurations of
GM microstructural/volumetric alterations were identified. (a) Co-localization of
GM atrophy with significant reduction of MT, R1, and/or R2*, usually observed in
primary cortices. (b) Microstructural modifications without significant GM loss:
hippocampus and paralimbic cortices, showing reduced MT and/or R1 values
without significant atrophy. (c) Atrophy without significant change in microstruc-
ture, identified in deep GM nuclei. In conclusion, this quantitative multiparametric
voxel-based approach reveals three different spatially-segregated combinations of
GM microstructural/volumetric alterations in MS that might be associated with
different neuropathology.
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1 | INTRODUCTION
Multiple sclerosis (MS) has long been considered as a disease of the
sole white matter (WM). However, inflammation-induced demyelin-
ation and neurodegeneration are also found in cortical and deep
gray matters (GM), and expressed in different ways: focal lesions
(i.e plaques) and diffuse alteration (Calabrese et al., 2015;
Lassmann, 2018). Unfortunately, most GM damage escape detection
on conventional MRI (Hulst & Geurts, 2011). Quantitative MRI (qMRI)
potentially surmounts this limitation by quantifying physical proper-
ties of cerebral tissue and provides information about MS related
microstructural alterations within GM. Magnetization transfer
(MT) saturation, longitudinal (R1), and effective transverse (R2*) relax-
ation rates are differently sensitive to myelin and iron contents
(Hametner et al., 2018; Schmierer, Scaravilli, Altmann, Barker, &
Miller, 2004; Stüber et al., 2014) and were reported altered in MS cor-
tical and deep GM (respectively CGM and DGM), taken as bulk tissue
classes. In most studies, MT, R1, and R2* were found reduced in CGM
of MS patients, suggesting reduction in myelin and/or iron contents
(Filippi & Agosta, 2007; Lommers et al., 2019; Mainero et al., 2015;
Vrenken et al., 2006). Their alteration in DGM structures seems more
variable: MT is not consistently decreased (Filippi & Agosta, 2007;
Lommers et al., 2019; Mainero et al., 2015; Vrenken et al., 2006)
and R2* is either larger than (Elkady, Cobzas, Sun, Blevins, &
Wilman, 2017; Khalil et al., 2011; Ropele et al., 2014) or not signifi-
cantly different from healthy controls (HC) (Elkady et al., 2019;
Hernández-torres et al., 2018; Lommers et al., 2019). Furthermore, a
few studies measuring R1 within DGM did not show any alteration of
this parameter in MS population (Andica et al., 2019; Lommers
et al., 2019).
Importantly most of these studies did not characterize the spatial
distribution of GM microstructural alterations when considering sev-
eral quantitative parameters. In this paper, we precisely provide a
whole-brain voxel-based quantification (VBQ) of three qMRI
parameters—MT saturation, R1 and R2*, derived from data acquired
in a single MR session—and assess the spatial distribution of their
changes in a cross-sectional study which contrasted MS patients to
HC. Potential GM atrophy was also investigated by a concurrent
voxel-based morphometry (VBM) analysis.
Our study aimed at characterizing the spatial distribution of
microstructural and volumetric GM alterations induced by MS at the
regional level (i.e., voxel-wise). Results are presented as different spa-
tial combinations of atrophy and microstructural damages in cortical
and deep GM involvement, in MS compared with healthy controls.
2 | MATERIALS AND METHODS
2.1 | Participants
Seventy-two participants were initially included in the study
(Lommers et al., 2019): 36 patients with a diagnosis of MS according
to McDonald criteria 2010 (15 relapsing–remitting MS, 14 primary
progressive MS and 7 secondary progressive MS) and 36 healthy con-
trols (HC), matched for age and gender, free from neurological or psy-
chiatric disease. Patient inclusion criteria were: (a) age between
18 and 65 years, (b) Expanded Disability Status Scale (EDSS) ≤ 6.5;
(c) absence of relapse within the previous 4 weeks; (d) compatibility
with MRI. One relapsing–remitting MS patient was excluded because
of an imperfect image preventing an optimal normalization of MRI
data. Final demographic data are reported in Table 1. All participants
were assessed clinically by a qualified MS specialist (EL) on the EDSS,
Time 25-Foot Walk, 9-Hole Peg Test, oral Symbol Digit Modalities
Test and California Verbal Learning Test. Scores for the last 4 tests
were standardized to HC summary statistics and computed as a motor
and cognitive composite scores (Lommers et al., 2019). This study was
approved by the local ethic committee (B707201213806) and written
informed consent was obtained from each participant.
2.2 | MR image acquisition and spatial processing
MRI data were acquired on either of the following 3 T MRI-scanners:
Magnetom Allegra and Magnetom Prisma, Siemens Medical Solutions,
Erlangen, Germany. The whole-brain MRI acquisitions included a mul-
tiparameter mapping (MPM) protocol that has been gradually
optimized and validated for multi-centric acquisitions (Leutritz
et al., 2020; Tabelow et al., 2019; Weiskopf et al., 2013). It consists of
three co-localized series of 3D multi-echo fast low angle shot (FLASH)
acquisitions at 1 × 1 × 1 mm3 resolution and two additional calibra-
tion sequences to correct for inhomogeneities in the RF transmit field
(Lutti et al., 2012). The FLASH data sets were acquired with predomi-
nantly proton density (PD), T1, and MT weighting, referred to in the
following as PDw, T1w and MTw echoes. Volumes were acquired in
176 sagittal slices using a 256 × 224 voxel matrix. Details of the
MPM protocol used for this study are available as supplementary
data. An additional FLAIR sequence was recorded with spatial resolu-
tion 1 × 1 × 1 mm3 and TR/TE/TI = 5,000 ms/516 ms/1800 ms.
All data analyses and processing were performed in Matlab (The
MathWorks Inc., Natick, MA) using SPM12 (http://www.fil.ion.ucl.ac.
uk/spm) and its extensions. MT saturation, R1 and R2* quantitative
maps were estimated using the hMRI toolbox (http://hmri.info/) as
previously described (Tabelow et al., 2019). Briefly, echoes for T1w,
PDw, and MTw were extrapolated to TE = 0 to increase the signal-to-
noise ratio and get rid of the otherwise remaining R2* bias (Tabelow
et al., 2019). The resulting MTw and T1w (TE = 0) images were used
to calculate MT saturation and R1 quantitative maps. To maximize the
accuracy of the R1 and MT saturation maps, inhomogeneity in the flip
angle was corrected by mapping the B1 transmit field according to
the procedure detailed in (Lutti et al., 2012). In addition, intrinsically
imperfect spoiling characteristics were accounted for and corrected in
R1 map, using the approach described previously (Preibisch
et al., 2009). The MT saturation map differs from the commonly used
MT ratio (MTR, percent reduction in steady state signal) by explicitly
accounting for spatially varying T1 relaxation time and flip angles. MT
saturation shows a higher brain contrast to noise ratio than the MTR,
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TABLE 1 Participant characteristics
HC (n = 36) All patients (n = 35) RRMS (n = 14, 40%) PMS (n = 21, 60%)
Age, y, mean (SD) 45.86 (12.45) 46.2 (11.62) 37.14 (9.4) 52.23 (8.8)
Sex (F/M) 20/16 21/14 9/5 12/9
Treatment (first line/second line/non-validated therapies) 9/5/0 2/3/2
Disease duration, y, median (range) N/A 13 (0.5 to 35) 8 (0.5 to 28) 13 (2 to 35)
Baseline EDSS, median (range) 4 (1 to 6.0) 2 (1 to 5.5) 4.5 (3 to 6.0)
Motor score, mean (SD) 0.03 (0.72) −2.32 (2.24) −0.51 (1.21) −3.39 (2)
Cognitive score, mean (SD) 0.04 (0.75) −1.45 (1.74) −0.22 (0.9) −2.28 (1.68)
Scanner 1/scanner 2 11/25 25/10 10/4 15/6
Volumetric data, %, mean (SD)
Gray matter fraction (GMF) 52.76 (1.99) 49.55 (3.02)a
Lesion fraction N/A 1.82 (1.4)
Median MPM values summarized over the whole tissue class, mean (SD)
MT (p.u)
CGM 0.82 (0.09) 0.69 (0.27)a
DGM 0.98 (1.13) 0.87 (0.11)a
R1 (Hz)
CGM 0.64 (0.02) 0.62 (0.02)a
DGM 0.77 (0.06) 0.75 (0.05)b
R2* (Hz)
CGM 16.62 (1.02) 15.35 (1.16)a
DGM 22.04 (3.10) 21.71 (2.9)c
Note: ANOVA testing for differences between HC and MS patients.
Abbreviations: CGM, cortical gray matter; DGM, deep gray matter; GMF, gray matter fraction (GM/TIV volume); HC, healthy controls; LF, lesion fraction
(lesion/TIV volume); PMS, progressive multiple sclerosis (primary and secondary PMS); RRMS, relapsing–remitting multiple sclerosis; TIV, total intracranial
volume.
aDifferences statistically different at p < .0001.
bDifferences not statistically different, p = .06.
cDifferences not statistically different, p = .68.
F IGURE 1 Example of MPM quantitative maps for a specific MS patient. From left to right: 3 MPM quantitative maps (MT, R1, R2*), standard
FLAIR sequence image and FLAIR image overlaid with the estimated lesion mask. MT, magnetization transfer saturation; R1, longitudinal
relaxation rate (1/T1); R2*, effective transverse relaxation rate (1/T2*); Lesion mask, posterior probability map of lesion tissue thresholded at 90%
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leading to improved and more robust segmentation in healthy sub-
jects (Helms, Dathe, & Dechent, 2010). The R2* map was estimated
from all three multi-echo series using the ESTATICS model (Tabelow
et al., 2019). Example whole brain maps are shown in Figure 1. Note
that these MR sequences at 3 T are not sensitive enough to detect
focal cortical lesions, as previously described (Hulst & Geurts, 2011).
Quantification of cortical parameters is thus possibly confounded by
voxels located within cortical plaques.
MR images multi-channel segmentation and normalization were
performed with the standard “unified segmentation” (US) approach
for the HC and its US-with-Lesion extension, accounting for WM
lesions, for the MS patients. This part of the processing is largely
detailed in a previous publication (Lommers et al., 2019). Briefly, for
each MS patients, a preliminary lesion mask was derived from the
FLAIR images and used to update the “tissue probability maps” with
an extra lesion tissue class limited to the WM. This patient specific
extended TPM was then used in the US tool, therefore accounting for
the usual brain and head tissue plus the lesions (Phillips, Lommers, &
Pernet, 2016). Individual lesion fraction (LF, ratio of WM lesion load
to total intracranial volume) was computed afterwards from the seg-
mented tissue classes. For VBM analyses, GM probability map (includ-
ing cortical and deep GM) were spatially warped to standard space,
modulated by the Jacobian determinants of the deformations, and
smoothed with an isotropic Gaussian kernel (6 mm full width at half
maximum—FWHM). For VBQ analyses, the 3 quantitative maps were
normalized using the subject-specific deformation field but without
modulation. A tissue weighted smoothing (3 mm FWHM isotropic)
yielded smoothed tissue-specific multiparameter maps which opti-
mally preserved quantitative parameter values within each tissue class
(Draganski et al., 2011). Detailed analysis of the influence of spatial
deformations onto quantitative parametric values proved this method
to be largely insensitive to volumetric changes (i.e., atrophy) (Salvoni
et al., 2019). Finally, a GM mask was generated: the smooth modu-
lated warped individual GM, WM and CSF maps were averaged across
all subjects and the GM mask included voxels for which mean GM
probability was larger than that of WM or CSF and exceeded 20%
(Callaghan et al., 2014).
2.3 | Statistical analyses
Whole-GM voxel-wise VBM and VBQ statistical analyses, explicitly
using the GM mask, were carried out using a multiple linear regression
model embedded in the general linear model framework of SPM12.
MRI data were analyzed in a factorial design, with the 2 different
scanners as one factor and the group (MS vs. HC) as the second factor
(Stonnington et al., 2008). Age, gender and total intracranial volume
were entered as covariates of no interest. Differences between MS
patients and HC as well as interactions between groups and scanners
were tested by separate F-tests for each quantitative parameter (MT,
R1, R2*) and volume.
Post hoc t tests explored significant effects. Cluster-level infer-
ences were conducted at p < .05 after family-wise error rate (FWER)
correction for multiple comparisons across the whole GM (p < .0001
uncorrected cluster-defining threshold). These 2-sample t-tests identi-
fied significant group effects, over and above the normal spatially het-
erogeneous distribution of quantitative parameters (Deistung
et al., 2013) and accounting for potential unequal variance across
groups.
In the patient population, three F tests looked for significant
voxel-wise regression between each qMRI parameter and clinical
scores (EDSS, motor and cognitive composite scores) as well as lesion
fraction. Significance threshold was set at p < .05 FWER corrected at
cluster level (p < .0001 uncorrected cluster-defining threshold).
3 | RESULTS
Compared with HC, we identified significant loco-regional reductions
of MT saturation in GM of MS patients, bilaterally in Heschl's gyri,
posterior hippocampi and precentral gyri. MT was also significantly
reduced in right insula, right superior temporal gyrus, right angular
gyrus, left caudate, and cingulum as well as left postcentral gyrus
(Figure 2). R1 was significantly lower in MS patients, compared with
HC, within both hippocampi, left temporal gyri (middle, superior, infe-
rior), left insula, right sensory-motor cortex, right middle temporal
gyrus and right cingulum. Finally, we found significant clusters of
locally reduced R2* in left inferior and middle temporal gyri as well as
in left postcentral gyrus (Figure 2). We did not observe an increase of
any of these three qMRI parameters in MS patients compared with
HC. No significant parameter changes were observed between RRMS
and PMS, probably due to the small number of observations.
Extensive GM loss was observed in MS compared with HC in
bilateral precentral and Heschl's gyri, both thalami, both cunei, both
putamen, supero-inferior colliculi as well as in bilateral lingual gyri and
right posterior hippocampus (Figure 2).
Regressions between GM qMRI values and clinical scores (EDSS,
motor and cognitive composite scores) only showed that cognitive
score decreased with regional reduction of R1 within right middle
frontal gyrus. Furthermore MT, R1, and R2* negatively regressed with
lesion fraction in both thalami and caudate nuclei.
For a complete list of regions showing lower GM volume, lower
MT, R1, R2* values and significant regressions, see Tables S1 to S6 in
the supporting information section. Figure 3 illustrates the distribution
of each GM parameter (GM volume, MT, R1, R2*) extracted from four
different regions of interest (ROIs), across MS and HC participants.
Importantly, despite a clear effect of scanner on qMRI values
(essentially MT saturation), there was no significant group by scan
interaction, even at the set-level.
4 | DISCUSSION
The topography of microstructural and volumetric alterations in GM
of MS patients was assessed by a multiparametric voxel-based
approach, without prior prediction regarding MS damage location. We
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reasoned that the simultaneous voxel-wise quantification of physical
tissue parameters would enrich the understanding of MS pathology
by characterizing a typical microstructural and volumetric pattern,
over and above the inter-patient variability of disease presentation.
Importantly, our quantification of microstructural parameters is largely
insensitive to volumetric changes (Draganski et al., 2011; Salvoni
et al., 2019), thereby allowing for independently characterizing micro-
structural and volumetric changes. Quantitative MRI parameters (MT,
R1, R2*) inform us about GM microstructure (mainly myelin and iron
contents) (Hametner et al., 2018; Schmierer et al., 2004; Stüber
et al., 2014) while VBM estimates GM loss or atrophy secondary to
neurono-axonal loss and neuronal shrinkage (Klaver et al., 2015).
Finally, lesion load in the underlying WM was taken into account to
interpret GM alterations in parameter value (MT, R1, and R2*).
This multiparametric voxel-based strategy has seldom been
followed in MS: a single report on a cohort of 19 patients is available
(Engström, Warntjes, Tisell, Landtblom, & Lundberg, 2014). Conse-
quently, our results cannot be directly compared with the existing lit-
erature. A few voxel-based studies examined the spatial distribution
of MT ratio together with GM atrophy (Audoin et al., 2007; Crespy
et al., 2011; Khaleeli et al., 2007; Mallik et al., 2015). Fairly consistent
with those reported in other MS cohorts including RRMS and
PMS patients (Bodini et al., 2009; Ceccarelli et al., 2008; Khaleeli
et al., 2007; Mallik et al., 2015) our VBM results show significant GM
loss essentially in primary motor cortices, Heschl's gyri, cunei and
DGM nuclei (both thalami, both putamen, supero-inferior colliculi).
However, we did not find any significant atrophy within the cerebel-
lum possibly because of an unsatisfactory GM segmentation within
the posterior fossa. As for regions of lower MT saturation, they agree
with previous reports regarding CGM but not DGM (Audoin
et al., 2007; Khaleeli et al., 2007; Mallik et al., 2015). Again, compari-
son with literature is difficult because MT saturation estimated in the
current work represents an advanced estimation of magnetization
transfer over MT ratio. Moreover, one should keep in mind that we
used fairly conservative statistical thresholds (to control for the risk of
false positives) and that an absence of significant loco-regional differ-
ences between HC and MS patients does not prove their absence: it
might result from sparsely distributed, spatially variable across
patients, areas of low focal MT, R1, or R2*.
Statistical inference identified three combinations of microstruc-
tural/volumetric changes (Figure 2): (a) Co-localization of GM atrophy
with microstructural changes, usually observed in areas overhanging
the most abundant WM lesion load. Compared with HC, MS patients
show a significant reduction in MT saturation and/or R1 (both sensi-
tive to myelin content) co-localized with widespread GM atrophy in
bilateral sensory-motor cortices, Heschl's gyri and right hippocampus.
F IGURE 2 VBM and VBQ results superimposed on the group mean MT map. Green: Average WM lesion probability map of MS patients,
thresholded at 90% (a); Voxels showing a significant difference between MS and HC (thresholded at cluster level, p < .05 FWER-corrected):
decreased gray matter (GM) volume in red (b), MT reduction in blue (c), R1 reduction in yellow and R2* reduction (circled) in violet (d). The right
most column (MERGE) overlays the maps displayed in columns b, c, and d columns, same color scheme, and highlights the three different patterns
discussed in the main text (1 = Primary Neocortical Regions, 2 = Hippocampus, 3 = Deep Gray Matter Nuclei). Images are shown in neurologic
convention and the X/Y/Z coordinates indicate the slice position in millimeter in MNI space
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Significant R2* reduction is restricted to the left inferior and middle
temporal gyri as well as to the left postcentral gyrus. (b) Micro-
structural modifications without significant GM loss: the left hippo-
campus and paralimbic cortices (cingulate gyrus and insula) show
reduced MT and/or R1 values, without significant atrophy, suggesting
a demyelination of residual neurono-axonal tissue, a regional resil-
ience to atrophy or the antecedence of microstructural alterations
over neurodegeneration. (c) Significant atrophy without significant
change in microstructure: this pattern was especially identified in
DGM structures (thalami, putamen, supero-inferior colliculi), suggest-
ing the predominance of neurono-axonal loss in these regions. The
discrepancy between volumetric and microstructural changes high-
lights the complementarity of these MRI techniques in assessing GM
pathological changes in MS.
4.1 | Pattern 1: Primary neocortical regions
Several phenomena likely contribute to the combined demyelination
and neurodegeneration observed in primary auditory and sensory-
motor cortices. These regions show less anatomical variability than
other brain areas (e.g., prefrontal cortex), which facilitates the detec-
tion of commonalities across patients. They are connected with long-
range, densely myelinated tracts (Nieuwenhuys & Broere, 2017) that
are vulnerable to trans-synaptic—anterograde and retrograde—neu-
rono-axonal degeneration (Calabrese et al., 2015; Haider et al., 2016)
supposedly because of their intrinsically heavy metabolic load
(Calabrese et al., 2015) and their frequent involvement in focal WM
inflammation. Finally, because of their numerous folds, these regions
are more exposed to cerebrospinal fluid (CSF) stasis, supporting the
hypothesis that soluble factors produced in the CSF by lymphocytes
influence subpial demyelination, particularly in patients with progres-
sive MS (Magliozzi et al., 2018).
4.2 | Pattern 2: Hippocampus
The evidence of substantial demyelination of hippocampi beyond
atrophic areas constitutes a key contribution of this study and usefully
complements previous characterization of hippocampal damage in MS
(Rocca et al., 2018). Indeed, demyelination is detected postmortem in
53 to 79% of MS hippocampi (Dutta et al., 2011; Dutta et al., 2013;
Geurts et al., 2007) and recently in living patients by estimating GM
myelin volume fraction with MRI (Andica et al., 2019). Hippocampal
demyelination in MS is selectively associated with alterations in genic
expression profiles, triggering abnormalities in hippocampal axonal
traffic, synaptic plasticity, neurotransmitter homeostasis and memory
(Dutta et al., 2011; Dutta et al., 2013). This stresses the need for early
and specific MRI biomarkers for demyelination in MS. The mecha-
nisms underpinning the relative resilience of hippocampus to atrophy
in MS are beyond the scope of this study. Nevertheless, a few obser-
vations are consistent with our results. First, neuronal loss is
F IGURE 3 Illustration of the distribution of each GM parameter (GM volume, MT, R1, R2*) extracted from four different voxels, across MS
and HC subjects in four brain regions of interest: Left thalamus (x = −15, y = −27, z = 14); Left hippocampus (x = −31, y = −27, z = −7); Left
Heschl's gyrus (x = −37, y = −28, z = 10); Left precentral gyrus (x = −34, y = −6, z = 46). All voxels coordinates expressed in MNI space and
chosen as the local statistical maximum in the ROI. Statistical significance (*) set at p < .05 FWER-corrected for the whole GM volume
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inconsistently observed in demyelinated hippocampi while synaptic
density is systematically decreased (Dutta et al., 2011; Geurts
et al., 2007; Papadopoulos et al., 2009). By the same token, chronic
inflammation potentially enhances neurogenesis within dentate gyrus
(Rocca et al., 2015). Although the functional significance of these cel-
lular changes is still under debate (Pluchino et al., 2008; Zhao, Deng, &
Gage, 2008), they may balance neuronal loss, at the structural level
(Rocca et al., 2015).
4.3 | Pattern 3: Deep gray matter nuclei
Our results show a significant atrophy of DGM in MS and agree with
previous reports (Hulst & Geurts, 2011). Thalamic and putamen atro-
phy relates to significant neuronal and axonal loss. It occurs very early
in the disease course and exceeds cortical atrophy (Eshaghi
et al., 2018). Due its extensive reciprocal connections with cortical
and subcortical structures, thalami are particularly vulnerable to anter-
ograde and retrograde degeneration. This interpretation is supported
by the significant inverse relationship between each qMRI parameter
value (MT, R1, and R2*) within thalami and the lesion load, which sug-
gests that lesions in connecting WM tracts also alter thalamic micro-
structure. These neurodegenerative processes likely dominate local
inflammatory activity and oxidative injury which were also reported
(Haider et al., 2016) but were not sensitively assessed in this study.
4.4 | Limitations
This cross-sectional study was run on a relatively small sample size.
To preserve statistical power, the two MS phenotypes were pooled
together. We cannot rule out that results are partly driven by the
larger proportion of PMS over RRMS patients, although exploratory
tests did not show any significant difference between the two patient
groups when corrected for multiple comparisons. If considering results
significant at p < .001 uncorrected for multiple comparisons, PMS
patients showed reduction in MT, R1, and R2* in a number of regions
that were already detected in the contrast involving healthy control
and the whole MS population. This might indicate that demyelination
is even more severe as disease progresses. Because differences in
microstructure between RRMS and PMS patients are of paramount
importance, they will be assessed in future work, based on larger and
independent population samples.
The factorial design used in this study offers the possibility to test
separately the effect of disease and the effect of scanner, as well as
their interaction. The absence of significant group by scan interaction
allows us to disentangle the potential confound introduced by the
two different scanners and still reliably discuss the effect of disease
on GM microstructure. Furthermore, acquisition protocol has been
optimized, pointing out the opportunity for multi-centric studies
(Leutritz et al., 2020).
Finally, our results do not confirm previous reports linking tha-
lamic and hippocampal damage to motor performance and cognitive
dysfunction in MS patients (Eshaghi et al., 2018; Rocca et al., 2018).
Inferences were conservatively made after correction for multiple
comparisons over the whole GM, increasing the risk of Type II error.
In this preliminary study, we indeed considered that conservative
inferences had to be preferred to spurious results. Alternatively, it
might be the case that microstructural alterations precede the occur-
rence of clinical symptom: longitudinal studies are needed to answer
this question. Moreover, spinal cord lesions were not taken into
account although they impact motor performance.
5 | CONCLUSION
This multiparametric voxel-based approach identifies three different
spatially-segregated patterns of GM microstructural/volumetric alter-
ations in MS patients, that might be associated with different neuro-
pathology. The results highlight the usefulness of qMRI parameters
and their complementarity with volumetric techniques in assessing
GM status in MS.
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APPENDIX A. : Multi-echo 3D FLASH acquisition parameters
Magnetom ALLEGRA Magnetom PRISMA
PDw
TR 23.7 (ms) 24.5 (ms)
Flip angle 6 6
Bipolar gradient echoes/TE 6/TE 2.2–14.7 (ms) 8/TE 2.34–18.72 (ms)
T1w
TR 18.7 (ms) 24.5 (ms)
Flip angle 20 21
Bipolar gradient echoes/TE 6/TE 2.2–14.7 (ms) 8/TE 2.34–18.72 (ms)
MTw
TR 23.7 (ms) 24.5 (ms)
Flip angle 6 6
Bipolar gradient echoes/TE 6/TE 2.2–14.7 (ms) 6/TE 2.34–14.04 (ms)
Bandwidth 425 (Hz/Px) 465 (Hz/Px)
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